Share the post "Mutual Fund Data: Stock Market today Insights for – 26 Aug 2024"
Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
---|---|---|---|---|---|---|
Medplus Health Services | Icici Prudential Pharma Healthcare & Diagnostics (phd) Fund | Buy | 1M | 616.00 | Lavender Rose Investment | |
Icici Prudential India Opportunities Fund | Buy | 1M | 616.00 | Lavender Rose Investment | ||
Icici Prudential Innovation Fund | Buy | 604K | 616.00 | Lavender Rose Investment | ||
Icici Prudential Multi-asset Fund | Buy | 966K | 616.00 | Lavender Rose Investment | ||
Nitco | Jm Financial Asset Reconstruction Company | Sell | 510K | 90.83 | Na |
The 1M shares of Medplus Health Services have been purchased by the by Icici Prudential Pharma Healthcare & Diagnostics (phd) Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 1M shares of Medplus Health Services have been purchased by the by Icici Prudential India Opportunities Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 604K shares of Medplus Health Services have been purchased by the by Icici Prudential Innovation Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 966K shares of Medplus Health Services have been purchased by the by Icici Prudential Multi-asset Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 510K shares of Nitco have been sold by the by Jm Financial Asset Reconstruction Company through mutual funds at a price of ₹90.83 per share.
Medplus Health Services Limited
14,888.25
Net Sales
143.44
Net Profit
14,975.37
Total Income
14,797.50
Expenditure
668
Current Price
7,981
Market Cap
The financial snapshot for Medplus Health Services Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹14,888.25 million and total income was ₹14,975.37 million. The company's expenditure was ₹14,797.50 million, leading to a net profit of ₹143.44 million. Earnings per Share (EPS) for continuing operations were ₹1.20. The report also highlights other income of ₹87.12 million, finance costs of ₹246.58 million, and employee benefit expenses of ₹1,618.22 million. Depreciation and amortization costs were ₹600.30 million, while current and deferred taxes were ₹60.44 million and ₹-26.01 million, respectively. The total comprehensive income for the period stood at ₹143.44 million, with other comprehensive income net of taxes at ₹0.00 million.
With a market capitalization of ₹7,981 crore, the company’s stock is currently priced at ₹668. The historical trading range of the stock is ₹849 / 598. The P/E ratio is remarkably high at 105, suggesting a significant valuation. The book value stands at ₹132, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 6.66%, and the Return on Equity (ROE) is 4.10%. The debt-to-equity ratio is very low at 0.64, though the company shows a negative net cash flow of ₹-137 crore. The Piotroski score is 6.00, with the Graham Number pegged at ₹137. The Price-to-Book (P/B) ratio of 5.06 highlights a premium valuation.
Nitco Limited
702.22
Net Sales
-435.20
Net Profit
713.84
Total Income
1,149.04
Expenditure
83.6
Current Price
601
Market Cap
In the most recent financial analysis for Nitco Limited, key metrics demonstrate a solid performance. The net sales reached ₹702.22 million, with total income amounting to ₹713.84 million. Expenditure was recorded at ₹1,149.04 million, resulting in a net profit of ₹-435.20 million. EPS figures for continuing operations are ₹-6.06. Other notable figures include other income of ₹11.62 million, finance costs of ₹267.42 million, and employee benefit expenses totaling ₹127.95 million. Depreciation and amortization expenses were ₹71.46 million, with current tax at ₹0.00 million and deferred tax at ₹0.00 million. The total comprehensive income for the period was ₹-435.62 million, and other comprehensive income net of taxes was ₹-0.42 million.
The company's market cap is ₹601 crore, with a stock price of ₹83.6. The historical stock range has been between ₹95.0 / 17.7. Its Price-to-Earnings (P/E) ratio of indicates a high valuation. The book value per share is ₹-71.3, and it has a dividend yield of 0.00%. The ROCE is -14.0% and ROE is %. With a very low debt-to-equity ratio of , the company is minimally leveraged. However, it reports a negative net cash flow of ₹-3.92 crore. The Piotroski score of 2.00 and the Graham Number of ₹ show mixed financial indicators, while the Price-to-Book (P/B) ratio of suggests the stock is trading at a premium.